Catalog Number 106524INT |
Device Problems
Kinked (1339); Occlusion Within Device (1423)
|
Patient Problem
Reaction, Injection Site (2442)
|
Event Date 12/15/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
Fda approval for heartmate 3 lvas was received on 23 august 2017.The gtin unique device identifier for the commercial heartmate3 lvas is (b)(4).The referenced previous pump exchange occurred in april 2017 under the ide study.Approximate age of device ¿ 8 months.The patient remains ongoing on lvad support.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is complete.
|
|
Event Description
|
The patient was implanted with a left ventricular assist device (lvad) on (b)(6) 2017.It was reported that the patient was admitted to the hospital on (b)(6) 2017 due to intermittent low flow alarms.Ct angiography revealed a suspected twist in the outflow graft approximately in the area of the end-to-end graft anastomosis created during a previous pump exchange in (b)(6) 2017.The obstruction was successfully treated with a stent on (b)(6) 2017.Pump flow increased directly after the procedure.No additional information was provided.
|
|
Manufacturer Narrative
|
The report of a twist in the outflow graft was confirmed through the evaluation of the submitted ct images, which revealed a suspected twist in the outflow graft near the end-to-end anastomosis from the previous pump exchange; however, a specific cause for what led to this twist could not conclusively be determined.It was reported that a stent was placed in the outflow graft to treat the obstruction.The patient remains ongoing on lvad support and no further related issues have been reported.A review of the device history records revealed no deviations from manufacturing or quality assurance specifications.The manufacturer is closing the file on this event.
|
|
Manufacturer Narrative
|
Abbott has decided to initiate a voluntary field action for all lot numbers of heartmate iii distributed since september 2014.Internal investigation performed by abbott has determined there is a potential for an outflow graft occlusion due to twisting.Abbott performed a comprehensive investigation which included device analysis, manufacturing evaluation and trend analysis.The root cause identification determined that bend relief rotation is inconsistently translated to the outflow graft hardware.A risk/benefit analysis was performed and it was determined that despite the potential for an outflow graft occlusion due to twisting, the associated residual risks are low and are considered acceptable.As a corrective action, consignees have been notified of the potential occlusion due to twisting.Additionally, abbott will continue to trend complaints related to this event based on original event description and/or results of product evaluation.
|
|
Search Alerts/Recalls
|